Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC

Condition:   Staging IV NSCLC Intervention:   Drug: Rh-endostatin Sponsor:   Guangzhou Institute of Respiratory Disease Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials